Evolent Health
EVH
167 hedge funds and large institutions have $1.57B invested in Evolent Health in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 64 increasing their positions, 42 reducing their positions, and 14 closing their positions.
257% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 14
71% more capital invested
Capital invested by funds: $921M → $1.57B (+$650M)
52% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 42
50% more call options, than puts
Call options by funds: $3.93M | Put options by funds: $2.62M
27% more funds holding
Funds holding: 131 → 167 (+36)
21.23% more ownership
Funds ownership: 78.85% → 100.08% (+21%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$128M |
| 2 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$55.9M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$36.2M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$35.7M |
| 5 |
BlackRock
New York
|
+$32.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$28.7M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$16M |
| 3 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
-$15.4M |
| 4 |
PA
Perceptive Advisors
New York
|
-$8.9M |
| 5 |
Goldman Sachs
New York
|
-$5.78M |
EVH Hedge Fund Activity: Q2 2017 in Review
167 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2017, worth a combined $1.57B — up 71% from $921M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new EVH positions and 14 closed out — a net gain of 36 holders — while 64 added to existing stakes and 42 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $128M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $28.7M.
- 167 institutional investors held Evolent Health (EVH) as of Q2 2017, up from 131 in Q1 2017.
- Funds reported $1.57B of Evolent Health stock for Q2 2017, up 71% quarter-over-quarter.
- 50 funds opened new Evolent Health positions in Q2 2017 and 14 closed out, a net change of +36 holders.
- The largest Evolent Health buyer in Q2 2017 was Fidelity Investments, an estimated $128M added.
- The largest Evolent Health seller in Q2 2017 was TPG Group Holdings (SBS) Advisors, an estimated $28.7M sold.
Based on aggregated 13F filings for Q2 2017.